Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status.
Cortelezzi
A
A
Gritti
G
G
Del Papa
N
N
Pasquini
M C
MC
Calori
R
R
Gianelli
U
U
Cortiana
M
M
Parati
G
G
Onida
F
F
Sozzi
F
F
Vener
C
C
Bianchi
P
P
Deliliers
G L
GL
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000098:blood supply; D002452:Cell Count; D018450:Disease Progression; D004417:Dyspnea / Q000209:etiology; D042783:Endothelial Cells / Q000473:pathology*; D005221:Fatigue / Q000209:etiology; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000150:complications* / Q000503:physiopathology; D011087:Polycythemia Vera / Q000150:complications; D015995:Prevalence; D055728:Primary Myelofibrosis / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D013920:Thrombocythemia, Essential / Q000150:complications